BIM
NGNE icon

BlackRock Investment Management’s Neurogene NGNE Stock Holding History

BlackRock Investment Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$419K Hold
1,268
– – ﹤0.01% 3090
2016
Q3 		$339K Buy
1,268
+243
+24% +$49K ﹤0.01% 3154
2016
Q2 		$136K Hold
1,025
– – ﹤0.01% 3298
2016
Q1 		$181K Buy
1,025
+250
+32% +$48.6K ﹤0.01% 3181
2015
Q4 		$193K Hold
775
– – ﹤0.01% 3232
2015
Q3 		$218K Buy
+775
New +$179K ﹤0.01% 3237

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's NGNE Position: Q4 2016 in Review

BlackRock Investment Management held its Neurogene (NGNE) position steady in Q4 2016 at 1,268 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

BlackRock Investment Management first reported a position in NGNE in Q3 2015 and has held it in 6 quarters since. 49 funds tracked by Wall St. Rank hold NGNE as of Q4 2016.

  • BlackRock Investment Management held 1,268 shares of Neurogene worth $419K as of Q4 2016.
  • BlackRock Investment Management left its Neurogene share count unchanged in Q4 2016.
  • Neurogene made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3090 holding.
  • BlackRock Investment Management first reported a position in Neurogene in Q3 2015 and has held it in 6 quarters since.
  • 49 funds tracked by Wall St. Rank held Neurogene as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.